Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pfizer's new HSP 90 inhibitor PF-4942847 shows promise in triple-negative breast cancer in vivo

April 14, 2011

First-in-human data reported on GDC-0973 alone and in combination with GDC-0941

April 14, 2011

Abbott presents new ROCK-2 inhibitor with high specificity and selectivity

April 14, 2011

Janssen Pharma's new analgesics JNJ-40413269 and JNJ-40534832 show promise in vivo

April 13, 2011

Snapshots: New data on boceprevir in hepatitis C presented at EASL meeting

April 13, 2011

Suven Life Sciences' histamine H3 receptor antagonist improves cognitive performance in vivo

April 13, 2011

IND application filed for mTOR/PI3K-alpha inhibitor PWT-33597 based on in vivo antitumor action

April 13, 2011

Preclinical data provide support for GDC-0980 in phase I trials

April 13, 2011

Almac Discovery reports preclinical antiangiogenic activity for ALM-201

April 13, 2011

Astellas evaluates selective GlyT1 inhibitor AS-1522489-00 for psychiatric disorders

April 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....